Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study-Reference-Cited by-同舟云学术

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study

Published:2022 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Grenfell Rafaella Fortini Queiroz,Almeida Nathalie BF,Filgueiras Priscilla S.,Corsini Camila A.,Gomes Sarah VC,de Miranda Daniel AP,Lourenço Adelina J.,Martins Filho Olindo Assis,de Oliveira Jaquelline G.,Teixeira-Carvalho Andrea,Campos Guilherme RF,Nogueira Maurício Lacerda,Alves Pedro Augusto,Fernandes Gabriel R.,Castilho Leda R.,Lima Tulio M.,de Abreu Daniel PB,Alvim Renata G. F.,Silva Thais Barbara de S.,Jeremias Wander de J.,Otta Dayane A.,Campi-Azevedo Ana Caroline

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference23 articles.

1. The first 12 months of COVID-19: a timeline of immunological insights;Carvalho;Nature Reviews Immunology,2021

2. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile;Jara;The New England Journal of Medicine,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines;Human Vaccines & Immunotherapeutics;2023-01-02

2. Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant;Communications Medicine;2022-06-29